Gaylis, Norman B., M.D. Report issue

Academic/Hospital Phase 2 Phase 3 Phase 4

Organization Overview

First Clinical Trial
2007
NCT00425932
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2018

Timeline

NOW
  • Now

Alternative names

Gaylis, Norman B., M.D.

Active Ingredients

Drugs in Phase 4 Trials (1)

corticotropin (acthar) (1 trial)

Drugs in Phase 3 Trials (1)

sarilumab (kevzara) (1 trial)

Drugs in Phase 2 Trials (1)

rituximab (rituxan) (1 trial)

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Arthritis (Phase 4)

Arthritis, Rheumatoid (Phase 4)

Overview

  • Highest Phase: Phase 4
  • # of Trials: 3
  • # of Trial APIs: 3